Search:
This item requires a subscription.
What’s in the asthma pipeline over the next ten years? RDIP, Volume 19, Number 1.
It has proved extraordinarily difficult to develop new classes of drug for the treatment of asthma and most new treatments have been improvements of existing classes of drugs, such as corticosteroids and b2-agonists. Furthermore, existing treatments for asthma are highly effective if used correctly, so that there is little room for improvement in the management of the majority of patients. However, several new treatments are currently in development for asthma therapy.1
To view this item, select one of the options below:
Purchase access
Sign in
email address
Password
Important
All the articles are in PDF format.
To view the articles you will need Adobe Acrobat Reader.
To download a copy, free of charge, please click here.